NGM·Healthcare·$1.9B·#92 / 520 in Healthcare
VCEL Vericel Corporation
65SOLID
CATEGORY BREAKDOWN
GROWTH26
QUALITY80
STABILITY93
VALUATION61
GOVERNANCE38
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+16.5%
26
> 50% strong
Gross Margin
Revenue retained after direct costs
74.4%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
27.2%
78
< 25% strong
Price / Sales
Market cap relative to trailing revenue
6.7x
61
< 3x strong
Rule of 40
Growth rate plus operating margin
20
51
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.5%
12
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.4%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE VCEL WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when VCEL's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.